Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Virology
-
1. Principles of virology
- Prof. Vincent Racaniello
-
2. The type I interferon system and viruses
- Dr. Adolfo Garcia-Sastre
-
3. Immune responses to viruses
- Prof. Paul Klenerman
- Emerging Pathogens
-
4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
5. Emerging respiratory viruses - discoveries between 2001 and 2005
- Prof. Ron Fouchier
-
6. Usage of vaccines and therapeutics in public health emergencies 1
- Prof. Gary Kobinger
-
7. Usage of vaccines and therapeutics in public health emergencies 2
- Prof. Gary Kobinger
-
8. Influenza virus pandemics: past and future
- Prof. Peter Palese
-
9. SARS-CoV and other emerging coronaviruses
- Prof. Ralph Baric
-
10. Dengue, Zika and Chickungunya viruses
- Prof. Ana Fernandez-Sesma
-
11. Paramyxoviruses: biology & pathogenesis
- Prof. Benhur Lee
-
12. Antiviral drugs (non-HIV)
- Prof. Megan Shaw
-
13. Biodefense challenges
- Dr. David Franz
- Important Pathogens and their Diseases
-
14. Natural history and pathogenesis of herpes virus infections
- Prof. Richard Whitley
-
15. Cytomegalovirus biology
- Prof. Domenico Tortorella
-
16. Hepatitis C virus: discovery, cure and protection
- Dr. Matthew Evans
-
17. Fundamentals of HIV biology
- Prof. Viviana Simon
-
18. Measles
- Prof. Diane E. Griffin
-
19. Monkeypox virus, vaccines, and therapeutics
- Prof. Rachel Roper
- New Frontiers
-
22. Viruses as anticancer weapons
- Prof. Roberto Cattaneo
-
23. Novel approaches to diagnosis of viral infections
- Prof. W. Ian Lipkin
-
24. The Global Virus Network: collaboration to address pandemic and regional threats
- Prof. Sten H. Vermund
-
25. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
- Archived Lectures *These may not cover the latest advances in the field
-
26. Principles of virology I
- Prof. Richard Condit
-
27. Principles of virology II
- Prof. Richard Condit
-
28. Complex DNA viruses: herpes virus
- Dr. John Blaho
-
29. Adeno-associated viruses (AAV)
- Prof. Kenneth Berns
-
30. Poxviruses: smallpox (variola), vaccinia and monkeypox
- Prof. Paula Traktman
-
31. Can HPV testing be the sole primary cervical screening modality?
- Prof. Jack Cuzick
-
32. From viruses to oncolytics
- Prof. Roberto Cattaneo
-
33. Non HIV antivirals
- Prof. Mary Klotman
-
34. Gastroenteritis viruses
- Prof. Mary Estes
-
35. Biodefense challenges
- Dr. Connie Schmaljohn
-
37. The past, present and future of vaccination
- Prof. Stanley Plotkin
-
38. Filoviruses
- Dr. Christopher Basler
-
39. Bunyaviruses
- Prof. Richard Elliott
-
40. The immunobiology of HIV
- Prof. Norman Letvin
-
41. Hepatitis C and HCV
- Prof. Stanley Lemon
Printable Handouts
Navigable Slide Index
- Introduction
- Biology & pathogenesis of paramyxoviruses
- Paramyxoviruses are one of the most contagious viral pathogens that infect humans
- Classification of paramyxoviruses
- Nipah and Hendra virus
- Nipah and Hendra virus: risk group 4 select agents
- Metagenomic studies
- Evidence for henipavirus spillover
- Coalition for Epidemic Preparedness Innovations (CEPI), 2024–2026
- Characteristic features of paramyxoviruses (1)
- Canine distemper virus (CDV)
- RNA editing of the P gene
- P-derived gene products (V, W, C) are classical PMV IFN-antagonists
- Examples of interferon antagonism
- Characteristic features of paramyxoviruses (2)
- Paramyxovirus life cycle
- Characteristic features of paramyxoviruses (3)
- Structure of fusion protein (F) and receptor binding protein (RBP)
- Receptor binding protein (RBP)
- PIV5 HN example
- Fusion is mediated by the F protein: class 1 fusion protein
- Models for paramyxovirus fusion activation
- Syncytia formation (NiV-F/RBP)
- Lack of antigenic drift in paramyxoviruses compared to other RNA viruses
- PMV envelope genes are highly constrained and intolerant to transposon insertions
- Paramyxovirus receptors
- Species-specific CD150
- Henipavirus receptor usage & pathogenesis
- Concordance of ephrin-B2 expression pattern with known cellular tropism of Nipah virus
- All henipaviruses use ephrin-B2, some use ephrin-B3
- Receptor tropism and Nipah virus pathogenesis (1)
- Receptor tropism and Nipah virus pathogenesis (2)
- EFNB2 and EFNB3 expression in tissues
- Summary
Topics Covered
- Classification of paramyxoviruses
- Nipah and Hendra virus -Characteristic features of paramyxoviruses
- Interferon antagonism
- Paramyxovirus life cycle
- Fusion protein (F) and receptor binding protein (RBP)
- Models for paramyxovirus fusion activation
- Paramyxovirus receptors
- Receptor tropism and Nipah virus pathogenesis
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Lee, B. (2024, August 29). Paramyxoviruses: biology & pathogenesis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 11, 2024, from https://doi.org/10.69645/CSHO1592.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Benhur Lee.
I'm a professor of
Microbiology at
the Icahn School of
Medicine at Mount Sinai.
Today, we're going to talk
about paramyxoviruses,
their biology and
pathogenesis with
a special emphasis
on Nipah virus,
a dangerous and
virulent pathogen
that you'll hear about today.
0:25
Set the stage. This
is the outline
of the topics I'll
cover in today's talk.
I will start with
an introduction
to put the paramyxoviruses
in context.
Then I'll talk briefly about
the zoonotic nature
and virulence of
Nipah virus which belongs to
a group of viruses
called Henipavirus.
Then I will mention
the general
characteristic features
of paramyxoviruses and
in so doing talk
about the targets
for therapeutic interventions
and drug development.
Lastly, I will end with talking
about Henipavirus
receptor usage,
how it gets into
certain cells and
how that is related
to its pathogenesis.
1:12
To put it in context,
paramyxoviruses are one of
the most contagious viral
pathogens that infect humans.
As you can see from
the table below,
these are the various diseases
that most people may have
heard of and we
think that you know
the immediately past pandemic
SARS-CoV-2 was quite bad
and scientists characterize how
contagious an agent
is by the R_0 value.
This is the basic
reproductive number which
quantifies the contagiousness or
transmissibility of
infectious pathogens.
As you can see down there
at the bottom of the list,
SARS-CoV-1 and SARS-CoV-2
are about 2-5.
The big 1918 pandemic
influenza is also about 2-5.
Ebola that was all over the
news was only about 1.5-2.5.
But looking at measles
and mumps, which are
the prototypical paramyxoviruses
that most people have heard
of have extremely
high R_0 values.
In fact, measles
was thought to be
the most contagious
viral pathogen that we
know of and that's why we study
paramyxoviruses and
especially Nipah.
Currently, Nipah
virus has an R_0 of
less than one which means that
it's likely not to
result in an epidemic.
But if it ever evolves
to have a high R_0,
we would be in big
trouble because
Nipah viruses are much more
deadly than measles and mumps.